2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Eculizumab - Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant | Phase 3 | Completed | Cedars-Sinai Medical Center | 36 | 2012-11-01 | 2021-05-03 |
| Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration PCI - Left Ventricular Dysfunction | Phase 3 | Completed | Asklepios proresearch | 20 | 2006-02-01 | 2009-07-14 |
Ventricular Dysfunction, Left (2) · Complement Component 3 Deficiency, Autosomal Recessive (1) · Myocardial Infarction (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Ventricular Dysfunction (2) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
eculizumab (1)
Asklepios proresearch (1) · Cedars-Sinai Medical Center (1)
Germany (1) · United States (1)
Jignesh Patel, M.D., Ph.D. (1) · Karl-Heinz Kuck, Prof. Dr. med. (1)
2005 (1)